QDIS Blog

A blog about chemistry, drug development, science, and technology

December 19, 2006

Siegfried Sells Manufacturing Site to Celgene

by Ed Vawter @ 1:53 pm.  Filed under Pharma News

It appears that Siegfried has agreed to sign over their manufacturing facility at their site in Zofingen, Switzerland to Celgene for $45.7 million USD.

Siegfried signs over capacity to Celgene in €34.9m deal:

This will occur in early 2007 and Celgene will use the site for Revlimid API. This is an interesting development since I’m not aware of other contract manufacturers selling a facility to a main stream pharma or biotech company.

Other Resources

Siegfried Press Release PDF (English)

Technorati Tags: ,

Email Ed Vawter



Related Posts:
  • Contract Manufacturing Business to Exceed $26 Billion
  • AMRI Acquires Manufacturing Facilities in India
  • Drug Safety from Pharmaceutical Manufacturing
  • Contract Pharmas Contract Services Outlook for 2007
  • 3M Sells Pharma Business to Three Different Companies

    • Bookmark it with: | del.icio.us del.icio.us | Digg It Digg it | Furl Furl | Simpy Simpy | Spurl Spurl | My! Yahoo My Yahoo! |

    Leave a Reply

    [powered by WordPress.]

    QDIS: blogging about chemistry, drug development, science and technology.

    Internal Links

    Categories

    Search This Blog

    Archives

    December 2006
    S M T W T F S
    « Nov   Jan »
     12
    3456789
    10111213141516
    17181920212223
    24252627282930
    31  

    Search Entire Site

    Subscribe (It's Free!)

    Performancing

    Chemistry, science, and technology for the future.

    logo2

    General Links

    Blog Links

    Chemistry Journal Feeds

    Chemistry Feeds

    35 queries. 1.105 seconds